Monoclonal antibody L9LS prevents malaria infection in adults
1. In this small phase one clinical trial, L9LS administration protected healthy adults from contracting a malarial infection. 2. No ...
1. In this small phase one clinical trial, L9LS administration protected healthy adults from contracting a malarial infection. 2. No ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.